Abstract |
The aim of this study was to investigate the possible role of the CCR5 59029 A→G promoter point mutation polymorphism in determining the susceptibility to rheumatoid factor-positive and rheumatoid factor-negative rheumatoid arthritis. This polymorphism was assessed in 85 seropositive and 39 seronegative rheumatoid arthritis patients and in 126 healthy individuals of the same geographic and ethnic origin. We found an increase in the genetic frequency of the A allele in the 59029 A→G promoter region of the CCR5 receptor in patients with rheumatoid arthritis compared with healthy controls (p = 0.01; OR = 1.5, 95% CI (1.0-2.2). Likewise, the homozygous state for the A allele was found to be more frequent in rheumatoid arthritis patients, again when compared with healthy controls (p = 0.03; OR = 1.8, 95% CI 1.0-3.0). The increased frequency of the A allele was more evident in the more benign, seronegative rheumatoid arthritis group when compared with controls (p = 0.003; OR 2.4 95% CI 1.3-4.4), and when combining the A homozygous and the AG heterozygous patients compared with healthy subjects. These results suggest that this CCR5 promoter polymorphism seems to play an important role in determining different clinical courses in both forms of rheumatoid arthritis.
|
Authors | Guadalupe Lima, Janette Furuzawa-Carballeda, Dolores Ramos-Bello, Juan Jakez-Ocampo, Virginia Pascual-Ramos, Carlos A Núñez-Alvarez, Julio Granados, Luis Llorente |
Journal | European cytokine network
(Eur Cytokine Netw)
Vol. 23
Issue 2
Pg. 25-8
(Jun 2012)
ISSN: 1952-4005 [Electronic] France |
PMID | 22665517
(Publication Type: Journal Article)
|
Chemical References |
- Receptors, CCR5
- Rheumatoid Factor
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Arthritis, Rheumatoid
(genetics, immunology)
- Female
- Genetic Predisposition to Disease
- Genotype
- Humans
- Male
- Middle Aged
- Polymorphism, Single Nucleotide
- Promoter Regions, Genetic
- Receptors, CCR5
(genetics)
- Rheumatoid Factor
(blood)
|